Free Trial

Meritage Portfolio Management Acquires New Holdings in National Health Investors, Inc. (NYSE:NHI)

National Health Investors logo with Finance background

Meritage Portfolio Management acquired a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The firm acquired 43,736 shares of the real estate investment trust's stock, valued at approximately $3,230,000. Meritage Portfolio Management owned about 0.09% of National Health Investors as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of NHI. SG Americas Securities LLC bought a new stake in shares of National Health Investors during the 1st quarter worth $808,000. Farther Finance Advisors LLC increased its holdings in National Health Investors by 5,000.0% during the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock worth $68,000 after buying an additional 900 shares during the last quarter. Victory Capital Management Inc. raised its position in National Health Investors by 21.8% in the fourth quarter. Victory Capital Management Inc. now owns 29,723 shares of the real estate investment trust's stock worth $2,060,000 after acquiring an additional 5,318 shares during the period. Millennium Management LLC boosted its stake in National Health Investors by 1,967.0% in the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after acquiring an additional 464,727 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of National Health Investors by 2.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 876,839 shares of the real estate investment trust's stock valued at $60,765,000 after acquiring an additional 24,462 shares during the period. Institutional investors own 62.51% of the company's stock.

National Health Investors Stock Performance

Shares of NHI traded up $0.28 during trading hours on Friday, hitting $70.80. The company's stock had a trading volume of 123,629 shares, compared to its average volume of 247,896. The business has a 50 day simple moving average of $72.84 and a two-hundred day simple moving average of $71.58. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 16.55 and a quick ratio of 16.55. The company has a market cap of $3.31 billion, a price-to-earnings ratio of 22.48, a PEG ratio of 4.27 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The business had revenue of $68.87 million during the quarter, compared to analyst estimates of $85.13 million. During the same period in the previous year, the business earned $1.10 EPS. National Health Investors's revenue was up 9.6% compared to the same quarter last year. On average, equities analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.08%. National Health Investors's payout ratio is 114.29%.

Analyst Ratings Changes

A number of research firms recently commented on NHI. Truist Financial raised shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price target on the stock in a report on Wednesday. Wedbush raised National Health Investors to a "strong-buy" rating in a research report on Wednesday. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, National Health Investors presently has an average rating of "Moderate Buy" and an average price target of $85.75.

Check Out Our Latest Analysis on NHI

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines